Kolexia
Sauzay Chloé
Pharmacien
Hôpital Hôtel-Dieu Nantes
Nantes, France
49 Activités
880 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome hépatocellulaire Tumeurs du foie Tumeurs de la tête et du cou COVID-19 Carcinome épidermoïde Néphrocarcinome Hypoxie Gammapathie monoclonale de signification indéterminée

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment.
iScience   24 avril 2023
Beneficial outcomes and epidemiologics of atypical electrophoretic profiles arising after allogeneic hematopoietic stem cell transplantation for myeloid malignancies.
Current research in translational medicine   19 novembre 2021
Analysis of Mesencephalic Astrocyte-derived Neurotrophic Factor in Multiple Myeloma.
Anticancer research   13 septembre 2021
A simple score (Biovid-19) based on biological parameters predicts transfer to intensive care units and death in COVID-19 patients.
Current research in translational medicine   04 mars 2021
Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases.
Case reports in oncology   14 juillet 2020
COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF.
Journal of neurology   11 juin 2020
Emerging Roles of the Endoplasmic Reticulum Associated Unfolded Protein Response in Cancer Cell Migration and Invasion.
Cancers   06 mai 2019
CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule.
Frontiers in cell and developmental biology   26 avril 2019
Early decrease in serum amphiregulin or vascular endothelial growth factor levels predicts sorafenib efficacy in hepatocellular carcinoma.
Oncology reports   10 décembre 2018
A pan-cancer study of the transcriptional regulation of uricogenesis in human tumours: pathological and pharmacological correlates.
Bioscience reports   19 septembre 2018